0 Commenti
0 condivisioni
854 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Biologics and Biosimilars Market by 2031 – Segmentation Analysis, Trends, and Key PlayersThe biologics and biosimilars market is poised for significant growth over the next decade, driven by rising demand for advanced therapies to treat chronic, autoimmune, and life-threatening diseases. Biologics, complex medicines derived from living organisms, are increasingly preferred for their targeted therapeutic effects, while biosimilars offer highly similar alternatives at reduced costs,...0 Commenti 0 condivisioni 962 Views 0 Anteprima
-
Global Biologics Contract Development Market Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2025-2034The market research for the global Biologics Contract Development market is an accumulation of first-hand facts and quantitative and qualitative evaluation and analysis for the forecast period (2024-2032). The report offers a comprehensive assessment of macro-economic indicators, parent market trends, and several factors influencing the market dynamics. In addition, it also...0 Commenti 0 condivisioni 777 Views 0 Anteprima
-
Next-Gen Biologics and Cell Therapies Propel Advanced Therapeutics Market ForwardDetailed Analysis of Executive Summary Advanced Therapeutics Market Size and Share Global Advanced Therapeutics market size was valued at USD 11.52 billion in 2024 and is projected to reach USD 21.90 billion by 2032, with a CAGR of 8.40% during the forecast period of 2025 to 2032. Advanced Therapeutics Market research report is a great backbone for the expansion of Advanced...0 Commenti 0 condivisioni 2K Views 0 Anteprima
-
North America Adalimumab Market Growth Outlook Supported by Biologics Demand & Autoimmune Treatment Expansion"In-Depth Study on Executive Summary North America Adalimumab Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the adalimumab market in the forecast period 2023-2030. The expected CAGR of adalimumab market is tend to be around 5.40 % in the mentioned forecast period. The market was valued at USD 16,879.8 million in 2022, and it would grow upto USD...0 Commenti 0 condivisioni 972 Views 0 Anteprima
-
North America Biologics Market: Dynamics, Trends, and Future Outlook (2023-2031)The North America biologics market is witnessing substantial growth driven by technological advancements, increasing prevalence of chronic diseases, and rising investments in research and development. Biologics, which include monoclonal antibodies, vaccines, recombinant proteins, and gene therapies, are transforming modern healthcare by offering targeted and highly effective treatments. The...0 Commenti 0 condivisioni 24 Views 0 Anteprima
-
Spinal Devices and Biologics Market Opportunities: Growth, Share, Value, Size, and Scope"Executive Summary Spinal Devices and Biologics Market : Data Bridge Market Research analyses that the spinal devices and biologics market which is USD 8478.94 million in 2022, is expected to reach USD 29773.40 million by 2030, at a CAGR of 17.00% during the forecast period 2023 to 2030. An international Spinal Devices and Biologics Market research report is an absolute...0 Commenti 0 condivisioni 3K Views 0 Anteprima
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Commenti 0 condivisioni 997 Views 0 Anteprima
-
Biosimilars Market Opportunities for Pharma and Biotech CompaniesThe increasing role of biosimilars in hospital treatment protocols is another factor driving market growth. Hospitals are adopting biosimilars to manage healthcare budgets effectively. This shift is improving patient access to essential biologic therapies. The global Biosimilars Market is experiencing remarkable growth as healthcare systems increasingly adopt cost-effective alternatives...0 Commenti 0 condivisioni 2K Views 0 Anteprima
-
Can Immune-Modulating Biologic Drugs Redefine Cancer Treatment Worldwide?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Market Size and Share Analysis Report CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period This Immune-Modulating...0 Commenti 0 condivisioni 2K Views 0 Anteprima
-
cGMP Process Development Market to Reach USD 6.06 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032. cGMP process development represents the critical discipline of systematically designing,...0 Commenti 0 condivisioni 342 Views 0 Anteprima
-
cGMP Process Development Market to Reach USD 6.06 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032. cGMP process development represents the critical discipline of systematically designing,...0 Commenti 0 condivisioni 338 Views 0 Anteprima
-
Comprehensive Market Overview and Strategic Analysis of the Drugs of Bioengineered Protein Market 2034The Drugs of Bioengineered Protein Market report presents a detailed evaluation of the global landscape of bioengineered protein therapeutics, focusing on industry trends, segmentation, and growth trajectories that are reshaping modern healthcare. This expansive market includes a diverse range of biologic drugs such as cytokines and chemokines, peptide hormones, peptide antibiotics, monoclonal...0 Commenti 0 condivisioni 595 Views 0 Anteprima
-
How Is Fermentation Technology Revolutionizing Pharmaceutical API Production?Global Executive Summary Fermentation-Derived Pharmaceutical API Market: Size, Share, and Forecast CAGR Value The global fermentation-derived pharmaceutical API market size was valued at USD 841.50 million in 2025 and is expected to reach USD 1689.08 million by 2033, at a CAGR of 9.10% during the forecast period The complete Fermentation-Derived...0 Commenti 0 condivisioni 335 Views 0 Anteprima
-
In-Depth 2031 Forecast: Drug Development Market Growth, Innovation, and Competitive LandscapeDrug development is the pathway through which potential drug candidates are evaluated for medical use. Scientists study their pharmacological effects, dosage, and side effects. Only successful candidates proceed to commercial production. Drug Development Market In Depth Analysis The Drug Development Market is expected to register a CAGR of 9.2% from 2025 to 2031, reflecting strong...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Is the Global EPO Drugs Market Expanding With Rising Chronic Kidney Disease and Anemia Cases?Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...0 Commenti 0 condivisioni 2K Views 0 Anteprima
Pagine in Evidenza
Sponsorizzato
Sponsorizzato